» Articles » PMID: 16791018

Co-infection with HIV and Hepatitis C Virus in Former Plasma/blood Donors: Challenge for Patient Care in Rural China

Overview
Journal AIDS
Date 2006 Jun 23
PMID 16791018
Citations 36
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Illegal commercial plasma donation in the late 1980s and early 1990s caused blood-borne infections in China.

Objectives: To estimate the prevalence of HIV and hepatitis C virus (HCV) infections and to identify associated risk factors in central China with a history of illegal plasma collection activities.

Design And Methods: A cross-sectional study was carried out in 2004, in which all adult residents in four villages in rural Shanxi Province were invited for a questionnaire interview and testing of HIV and HCV antibodies.

Results: Of 3062 participating villagers, 29.5% reported a history of selling whole blood or plasma. HIV seropositivity was confirmed in 1.3% of subjects and 12.7% were HCV positive. Their co-infection rates were 1.1% among all study subjects, 85% among HIV-positive subjects, and 8.7% among HCV-positive subjects. Selling plasma [odds ratio (OR), 22.5; 95% confidence interval (CI), 16.1-31.7; P < 0.001] or blood (OR, 3.1; 95% CI, 2.3-4.2; P < 0.001) were independently associated with HIV and/or HCV infections. Although a spouse's history of selling plasma/blood was not associated with either infection, the HIV or HCV seropositivity of a spouse was significantly associated with HIV and/or HCV infections (both OR, 3.2; 95% CI, 2.0-5.2 in men, 2.0-4.9 in women; P < 0.001). For men, residence in the village with a prior illegal plasma collection center (OR, 2.5; 95% CI, 1.7-3.7; P < 0.001) and for women, older age (OR, 3.4; 95% CI, 1.2-14.0; P = 0.04) were associated with HIV and/or HCV infections.

Conclusions: HIV and HCV infections are now prevalent in these Chinese communities. HIV projects should consider screening and care for HCV co-infection.

Citing Articles

Increasing trends of overweight and obesity in treatment-naive people living with HIV in Shenzhen from 2014 to 2020: an emerging health concern.

Li T, Sun L, He Y, Zhou Y, Xu L, Zhao F Front Public Health. 2023; 11:1186838.

PMID: 37900013 PMC: 10602863. DOI: 10.3389/fpubh.2023.1186838.


Current Therapies in Clinical Trials of Parkinson's Disease: A 2021 Update.

Prasad E, Hung S Pharmaceuticals (Basel). 2021; 14(8).

PMID: 34451813 PMC: 8398928. DOI: 10.3390/ph14080717.


Infer HIV transmission dynamics from gene sequences among young men who have sex with men in China.

Jin X, Cheng J, Lou J Infect Dis Model. 2021; 6:832-838.

PMID: 34322646 PMC: 8286960. DOI: 10.1016/j.idm.2021.06.003.


Hepatitis B and hepatitis C prevalence among people living with HIV/AIDS in China: a systematic review and Meta-analysis.

Yu S, Yu C, Li J, Liu S, Wang H, Deng M Virol J. 2020; 17(1):127.

PMID: 32831118 PMC: 7446115. DOI: 10.1186/s12985-020-01404-z.


Interventions to improve the HIV continuum of care in China.

Zhang X, Wang N, Vermund S, Zou H, Li X, Zhang F Curr HIV/AIDS Rep. 2019; 16(6):448-457.

PMID: 31776975 PMC: 10767704. DOI: 10.1007/s11904-019-00469-y.


References
1.
Benhamou Y, BOCHET M, Di Martino V, Charlotte F, Azria F, Coutellier A . Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients. The Multivirc Group. Hepatology. 1999; 30(4):1054-8. DOI: 10.1002/hep.510300409. View

2.
Wu Z, Liu Z, Detels R . HIV-1 infection in commercial plasma donors in China. Lancet. 1995; 346(8966):61-2. DOI: 10.1016/s0140-6736(95)92698-4. View

3.
Qian H, Yang Z, Shi X, Gao J, Xu C, Wang L . Hepatitis C virus infection in former commercial plasma/blood donors in rural Shanxi Province, China: the China Integrated Programs for Research on AIDS. J Infect Dis. 2005; 192(10):1694-700. PMC: 2730763. DOI: 10.1086/497148. View

4.
Dodd R . Plasma collection and donor safety in rural China. J Infect Dis. 2005; 192(10):1681-2. DOI: 10.1086/497154. View

5.
Zhang M, Sun X, Mark S, Chen W, Wong L, Dawsey S . Hepatitis C virus infection, Linxian, China. Emerg Infect Dis. 2005; 11(1):17-21. PMC: 3294338. DOI: 10.3201/eid1101.031005. View